Conference call on GHP’s Interim report January-September 2016


Invitation to attend GHP’s webcasted conference call regarding presentation of
the Interim report January-September 2016.
Time: Friday 28 October 2016 at 09.30 a.m. CET

The conference call will be held in English and the webcast will be available at
GHP’s website under Investor Relations or via the following link: GHP webcasted
conference call Friday 28 October
2016 (http://event.onlineseminarsolutions.com/r.htm?e=1283373&s=1&k=1CB6FDC1A2C2
7 
3454E141F6335F06323)

GHP’s CEO Daniel Öhman and Acting CFO Susanna Laursen will present the results
and answer questions. To participate in the conference call, and thereby be able
to ask questions, please dial in ten minutes prior on one of the following phone
numbers:

SE: +46 (0) 8-566 426 91 or
UK: +44 (0) 20 3008 9810

The press release for GHP’s Interim report January-September 2016 will be
released on Friday 28 October 2016 at 8.00 a.m. CET.

Before the conference call, slides will be available at the company website,
www.ghp.se under Investor Relations.

The conference call will also be recorded and available at www.ghp.se under
Investor Relations.

21 October 2016
Gothenburg, Sweden
GHP Specialty Care AB (publ)
Queries should be addressed to:
Susanna Laursen, Acting CFO, Tel: +46 709 61 64 64
GHP is an internationally active health care provider that operates specialist
clinics in a select number of diagnostic areas through the application of a
business model that is unique in the health care industry, where leading doctors
become partners and shareholders. Each clinic specialises in a particular
patient group, and this leads to increased efficiency and higher quality. This
is the cornerstone of GHP’s business philosophy – “Quality through
specialisation”. GHP shares are traded on the Small Cap list of Nasdaq Stockholm
under the ticker symbol “GHP”.

GHP Specialty Care AB (publ) | Corp. ID No. 556757-1103
Södra Hamngatan 45 | SE-411 06 Gothenburg | Sweden
Tel +46-31 712 53 00 | Fax +46-31 313 13 21 | www.ghp.se

This is a translation of the Swedish version of the press release. When in
doubt, the Swedish wording prevails.

Attachments

10217099.pdf